Qu Biologics Co-Founder’s Cancer Recovery Fuels Desire To Help Others

Promising experimental treatments for Crohn’s disease and lung cancer being developed by Qu Biologics Inc., a Canadian biotechnology company founded by former London Telecom mogul Rob Freeman and Vancouver-based physician Dr. Hal Gunn, are moving forward with Health Canada-approved clinical trials. Gunn said in a phone interview Feb. 5 that the Crohn’s trial, a placebo controlled randomized trial for adults taking place in Vancouver, needs 19 more participants in order to fill 60 total spots. More information is available at qucrohnstrial.com.

Hey, check out all the research scientist jobs. Post your resume today!